Risk of breast cancer in carriers of BRCA gene mutations
Grann, V.
New England Journal of Medicine 337(11): 788
1997
ISSN/ISBN: 0028-4793 PMID: 9289639 Document Number: 482012
Document emailed within 1 workday
Related Documents
Bremer, M.; Steinmann, D.; Dork, T.; Borger, J.; Rades, D.; Karstens, J.H. 2001: Bilaterales Mammakarzinom und Lokalrezidiv: Prävalenz von BRCA-1- und BRCA-2-Genmutationen an einem unselektionierten Kollektiv - Bilateral breast cancer and local relapse: a hospital-based study of the prevalence of BRCA 1 and BRCA 2 gene Mutations Strahlentherapie und Onkologie 177(7): 325-329Bit-Sava, E.M.; Belogurova, M.B.; Imianitov, E.N.; Balandov, S.G.; Korniushin, O.V.; Borisov, M.K. 2013: Methods of surgical prevention of breast cancer and of ovarian cancer in BRCA mutation carriers Voprosy Onkologii 59(2): 5-11
Kuhl, C.K. 2002: High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene) Journal of Experimental and Clinical Cancer Research: Cr 21(3 Suppl): 103-106
Carlson, K.; Chung, A.; Mirocha, J.; Donovan, C.; Estrada, S.; Siegel, E.; Giuliano, A.; Amersi, F. 2018: Menopausal Status and Outcomes of BRCA Mutation Carriers with Breast Cancer American Surgeon 84(10): 1584-1588
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Margaglione, M.; Di Castelnuovo, A.; Totaro, A.; Iacoviello, L.; Di Minno, G. 2000: Risk of myocardial infarction in carriers of mutations in the hemochromatosis-associated gene Thrombosis and Haemostasis 84(4): 726-727
Triantafyllidou, O.; Vlachos, I.S.; Apostolou, P.; Konstantopoulou, I.; Grivas, A.; Panopoulos, C.; Dimitrakakis, C.; Kassanos, D.; Loghis, C.; Bramis, I.; Vlahos, N.; Yannoukakos, D.; Fostira, F. 2015: Epidemiological and clinicopathological characteristics of BRCA-positive and BRCA-negative breast cancer patients in Greece Journal of BUON: Official Journal of the Balkan Union of Oncology 20(4): 978-984
Levavi, H.; Sabah, G. 2003: BRCA susceptibility genes--a review of current conservative management of BRCA mutation carriers European Journal of Gynaecological Oncology 24(6): 463-466
Gil, F. 1996: Hereditary breast cancer risk: factors associated with the decision to undergo BRCA 1 testing European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 5(6): 488-490
Olmos, D.; Castro, E. 2013: BRCA mutations in prostate cancer patients Clinical Advances in Hematology and Oncology: H&o 11(9): 598-599
Narod, S.A.; Sun, P.; Risch, H.A. 2001: Ovarian cancer, oral contraceptives, and BRCA mutations New England Journal of Medicine 345(23): 1706-1707
Hirsh-Yechezkel, G.; Chetrit, A.; Lubin, F.; Friedman, E.; Peretz, T.; Gershoni, R.; Rizel, S.; Struewing, J.P.; Modan, B. 2003: Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel Gynecologic Oncology 89(3): 494-498
Glebov, O.K.; McKenzie, K.E.; White, C.A.; Sukumar, S. 1994: Frequent p53 gene mutations and novel alleles in familial breast cancer Cancer Research 54(14): 3703-3709
Bignell, G.R.; Barfoot, R.; Seal, S.; Collins, N.; Warren, W.; Stratton, M.R. 1998: Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer Cancer Research 58(7): 1384-1386
Dueñas González, A.; Cruz Hernández, J.J.; Abad Hernández, M.M.; Ramos, M.; González Sarmiento, R. 1996: Greater sensitivity of the PCR-SSCP technique compared with immunohistochemistry for the detection of exon 5 and 6 mutations of gene 53 in breast cancer Medicina Clinica 106(19): 721-724
Bachega, Tânia.A.S.S.; Brenlha, E.M.L.; Billerbeck, A.E.C.; Marcondes, Jé.A.M.; Madureira, G.; Arnhold, I.J.P.; Mendonca, B.B. 2002: Variable ACTH-stimulated 17-hydroxyprogesterone values in 21-hydroxylase deficiency carriers are not related to the different CYP21 gene mutations Journal of Clinical Endocrinology and Metabolism 87(2): 786-790
Howard-McNatt, M. 2013: Pros and cons of screening for BRCA mutations North Carolina Medical Journal 74(6): 489-490
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Ben David, Y.; Chetrit, A.; Hirsh-Yechezkel, G.; Friedman, E.; Beck, B.D.; Beller, U.; Ben-Baruch, G.; Fishman, A.; Levavi, H.; Lubin, F.; Menczer, J.; Piura, B.; Struewing, J.P.; Modan, B. 2002: Effect of BRCA mutations on the length of survival in epithelial ovarian tumors Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 463-466
Wang, H-Chung.; Chiu, C-Fang.; Tsai, R-Yin.; Kuo, Y-Shun.; Chen, H-Shiang.; Wang, R-Fen.; Tsai, C-Wen.; Chang, C-Hsiang.; Lin, C-Chieh.; Bau, D-Tian. 2009: Association of genetic polymorphisms of EXO1 gene with risk of breast cancer in Taiwan Anticancer Research 29(10): 3897-3901